REAFINITY Trademark

Trademark Overview

On Monday, December 4, 2023, a trademark application was filed for REAFINITY with the United States Patent and Trademark Office. The USPTO has given the REAFINITY trademark a serial number of 79389538. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, September 15, 2025. This trademark is owned by Miltenyi Biotec B.V. & Co. KG. The REAFINITY trademark is filed in the Pharmaceutical Products category with the following description:

Reagents for medical diagnostic purposes; reagents featuring magnetic beads, antibody reagents, all being for medical or veterinary purposes; buffer solutions and reagents for use with medical apparatus, namely, separation apparatus, analysing apparatus, reactors and imaging apparatus for medical diagnostic purposes; reagents for processing biological material, namely, tissues, bone marrow, cells, blood and components thereof, all being for medical or veterinary purposes; diagnostic preparations and reagents for medical and veterinary use; cell culture media for medical and veterinary purposes; pharmaceutical preparations for cellular therapy for treating cancer and autoimmune disorders; chemical, biological and biochemical preparations used for therapeutic purposes, namely, in-vitro diagnostic (ivd) preparations for medical use; diagnostic reagents for medical or veterinary purposes
reafinity

General Information

Serial Number79389538
Word MarkREAFINITY
Filing DateMonday, December 4, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, September 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 7, 2025

Trademark Statements

Goods and ServicesReagents for medical diagnostic purposes; reagents featuring magnetic beads, antibody reagents, all being for medical or veterinary purposes; buffer solutions and reagents for use with medical apparatus, namely, separation apparatus, analysing apparatus, reactors and imaging apparatus for medical diagnostic purposes; reagents for processing biological material, namely, tissues, bone marrow, cells, blood and components thereof, all being for medical or veterinary purposes; diagnostic preparations and reagents for medical and veterinary use; cell culture media for medical and veterinary purposes; pharmaceutical preparations for cellular therapy for treating cancer and autoimmune disorders; chemical, biological and biochemical preparations used for therapeutic purposes, namely, in-vitro diagnostic (ivd) preparations for medical use; diagnostic reagents for medical or veterinary purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 16, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMiltenyi Biotec B.V. & Co. KG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Thursday, February 15, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, March 13, 2024NON-FINAL ACTION WRITTEN
Friday, February 16, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 20, 2024APPLICATION FILING RECEIPT MAILED
Thursday, March 7, 2024ASSIGNED TO EXAMINER
Thursday, April 4, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, April 24, 2024REFUSAL PROCESSED BY IB
Thursday, March 14, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, April 4, 2024REFUSAL PROCESSED BY MPU
Wednesday, May 1, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 1, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 6, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 7, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 28, 2024SUSPENSION LETTER WRITTEN
Tuesday, May 28, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, May 7, 2025NON-FINAL ACTION E-MAILED
Monday, July 14, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, July 15, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 15, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 15, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 1, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, August 28, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 28, 2024LETTER OF SUSPENSION E-MAILED
Friday, January 31, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, May 7, 2025NON-FINAL ACTION WRITTEN
Wednesday, May 7, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 14, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Thursday, August 28, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 28, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 4, 2025EXAMINERS AMENDMENT E-MAILED
Thursday, September 4, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 4, 2025EXAMINER'S AMENDMENT ENTERED
Thursday, September 4, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 4, 2025EXAMINERS AMENDMENT -WRITTEN

Related Keywords

reafinity medical reagents purposes diagnostic veterinary preparations apparatus namely biological being